Which cell type is CD2 (Cluster of Differentiation 2) positive in?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CD2 Expression in Lymphocyte Populations

CD2 is positive in T cells, as it is a cell surface glycoprotein expressed on virtually all mature T lymphocytes and natural killer (NK) cells, but not on B cells or hematopoietic stem cells. 1

CD2 Expression Pattern in Different Cell Types

CD2 (also known as LFA-2) is a key T-cell surface marker with well-defined expression patterns:

  • T cells: CD2 is expressed on virtually all mature T cells and is considered a pan-T cell marker alongside CD3, CD5, and CD7 1, 2

  • NK cells: CD2 is also expressed on most natural killer cells 3

  • B cells: CD2 is not expressed on B cells (CD19+, CD20+, CD79a+, PAX5+ cells) 1

  • Precursor B cells: CD2 is not expressed on precursor B cells 1

  • Hematopoietic stem cells (HSCs): CD2 is not expressed on HSCs 1

Functional Significance of CD2

CD2 serves two critical functions in T cell biology:

  1. Cell adhesion: CD2 functions as an adhesion molecule by binding to its ligand LFA-3 (CD58), which is expressed on antigen-presenting cells. This interaction facilitates the formation of the immunological synapse between T cells and antigen-presenting cells 4, 3

  2. T cell activation: CD2 participates in signal transduction and can function as a costimulatory molecule for T cell activation 3

Clinical Relevance

Understanding CD2 expression is important for:

  • Immunophenotyping: CD2 is used in flow cytometry panels to identify T cells and NK cells, particularly in the diagnosis of T-cell lymphomas and leukemias 2

  • T-cell large granular lymphocyte leukemia (LGLL-T): Diagnosis includes assessment of CD2 expression alongside other T-cell markers 2

  • Therapeutic targeting: CD2 is an attractive target for monoclonal antibodies intended for treatment of conditions characterized by undesired T cell activation 3

Common Pitfalls in CD2 Assessment

  • When performing flow cytometry for T-cell evaluation, it's important to include CD2 in panels with other T-cell markers (CD3, CD5, CD7) for comprehensive assessment 2

  • Interpretation of CD2 expression should be done in the context of other markers, as CD2 alone is not sufficient to definitively identify T cells 1

  • In some T-cell malignancies, CD2 expression may be preserved even when other T-cell markers are lost, making it a valuable diagnostic marker 2

In summary, CD2 is a characteristic marker of T cells and NK cells, but is not expressed on B cells, precursor B cells, or hematopoietic stem cells.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosis of T-Cell Large Granular Lymphocyte Leukemia (LGLL-T)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

CD2 Immunobiology.

Frontiers in immunology, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.